You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》中金:內地規範互聯網診療監管 料線上處方藥銷售受影響
中金髮表報告指,近日國家衛健委發佈關於互聯網診療監管細則(徵求意見稿),預計隨着線上覆診行爲流程的監管落地,行業中部分不規範的線上問診行爲或將在短期內解決,並對處方藥銷售的增量業務的放量節奏有一定程度負面影響,而對具備完善合規監管體系,完備診療購藥流程手段的頭部公司,集中度長期或將進一步提升。該行推薦京東健康(06618.HK),阿裏健康(00241.HK),並建議關注平安好醫生(01833.HK)。 該行認爲,合規監管是行業健康有序發展的重要保障,今次徵求意見稿從醫療機構監管,執業人員監管,業務監管,質量安全監管及監管責任等多角度出發,進一步明確互聯網診療行爲的邊界與細則。文件明確指出患者就診須提供具有明確診斷的病歷資料,並指出互聯網診療行爲當前僅限覆診; 加強藥品管理,禁止統方,補方問題發生等多項內容,並強調持續加強流程監管監督和定期審查工作。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account